add site
services
publishers
database
health videos
toolbar
stats
live show
health store
more stuff
JOIN/LOGIN
| advertise add site services publishers database health videos
| | about toolbar stats live show health store more stuff JOIN/LOGIN |
| Health World US Business Political Technology Entertainment Sports Popular |
New drug design looks top Notch against cancerChemistry World - Nov 12, 2009 A new type of drug that can block the switching on of certain genes in cancer cells has shown promise in mice. Researchers say their drug design strategy ... Cancer protein 'can be disarmed' BBC News Experimental protein for leukaemia NHS Choices Receptos Raises $25M in Series A FinancingGenetic Engineering News (press release) - Nov 23, 2009 Receptos is initially targeting the Edg family of receptor proteins, including S1P1, for structure-based drug design. The company hopes to expand its GPCR ... Receptos Completes $25M Series A Financing Business Wire (press release) Youths seek inspiration for anti-drug design competition7thSpace Interactive (press release) - Nov 7, 2009 Hong Kong (HKSAR) - Dozens of contestants of the "Anti-drug Heroes" design competition today (November 7) attended the competition¡¦s second sharing session ... New research: Insulin linked to core body temperatureDrug Store News (blog) - - 1 hour ago ... the possibility that differences in core temperature may play a role in obesity and may represent a therapeutic area in future drug design," added Osborn. ARYx Therapeutics Schedules Third Quarter 2009 Results Conference CallReuters - Nov 5, 2009 ARYx uses its RetroMetabolic Drug Design technology to design structurally unique molecules that retain the efficacy of these original drugs but are ... ARIAD`s AP24534 Featured in Cancer Cell Publication as a Potential First-in ...Reuters - Nov 2, 2009 AP24534 is a product of ARIAD`s structure-based drug design platform. ARIAD scientists first determined the structure of the T315I mutant of BCR-ABL to ... Ariad's AP24534 in Publication (NASDAQ:ARIA) FavStocks (blog) New Compound 'Preempts Resistance' of BCR-ABL Therapeutics Daily (press release) (registration) BioCryst Pharmaceuticals Inc. Reports Operating Results (10-Q)GuruFocus.com - Nov 6, 2009 BioCryst Pharmaceuticals Inc. is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat ... Medical potential for lizard venomThe Age - - Nov 24, 2009 He said the potential of lizard venoms in drug design and discovery was virtually unexplored. ''You've got compounds that are completely different,'' Dr Fry ... Insulin and core body temperature linkedUnited Press International - Nov 23, 2009 ... highlights the possibility that differences in core temperature may play a role in obesity and may represent a therapeutic area in future drug design. ... BioCryst Announces Pricing of Public Offering of Common StockPR Newswire (press release) - Nov 19, 2009 | How to call the show... 1) Make sure the show is live (see graphic above). 2) Dial 724-444-7444. 3) Enter Call ID# 27566 when prompted. 4) Follow the phone prompts to join the call. Would you like to be a special guest on the show? Send us an email which includes your contact information and the topic(s) that you would like to discuss. Listen to past shows featuring special guests...  Bernard von NotHaus (Liberty Dollar)Aubrey de Grey, PhDDr. Amanuel Sima, MDDr. Bard Levey, DDSNeal AdamsRobin Scovill (director)Richard Diaz (author)Dr. Kaayla T. Daniel, CCNChana de Wolf, (cryonics researcher)Dr. Mary Ruwart (author & scientist)Richard Diaz (author)Dr. Jason Helliwell, OB/GYN |
| ↑ top of page ↑ | about thumbshots |
